Tonix 製藥控股公司

SecurityTNXP / Tonix Pharmaceuticals Holding Corp.
InstitutionUBS Group AG
Latest Disclosed Ownership231,678 shares
Latest Disclosed Value $ 3,185,573
UBS Group AG reports 153.31% increase in ownership of TNXP / Tonix Pharmaceuticals Holding Corp.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 231,678 shares of Tonix Pharmaceuticals Holding Corp. (US:TNXP) valued at $3,185,572 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 91,459 shares of Tonix Pharmaceuticals Holding Corp.. This represents a change in shares of 153.31% during the quarter. The current value of the position is $2,564,675 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F TONIX PHARMACEUTICALS HLDG C COM NEW 890260839 231,678 140,219 153.31 3,186 123.04 0.0005
2026-01-29 2025-12-31 13F TONIX PHARMACEUTICALS HLDG C COM NEW 890260839 91,459 39,878 77.31 1,429 14.61 0.0002
2025-11-13 2025-09-30 13F TONIX PHARMACEUTICALS HLDG C COM NEW 890260839 51,581 29,118 129.63 1,246 54.21 0.0002
2025-08-14 2025-06-30 13F TONIX PHARMACEUTICALS HLDG C COM NEW 890260839 22,463 2,494 12.49 808 126.97 0.0001
2025-05-13 2025-03-31 13F TONIX PHARMACEUTICALS HLDG C COM NEW 890260839 19,969 19,969 357 0.0001
2022-08-10 2022-06-30 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 0 -254,952 -100.00 0 -100.00
2022-05-16 2022-03-31 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 254,952 -79,231 -23.71 58 -52.07 0.0000
2022-02-14 2021-12-31 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 334,183 334,172 3,037,927.27 121 0.0000
2021-11-15 2021-09-30 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 11 -8,179 -99.87 0 -100.00
2021-08-13 2021-06-30 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 8,190 8,179 74,354.55 9 0.0000
2021-05-12 2021-03-31 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 11 0 0.00 0 -100.00 0.0000
2021-02-11 2020-12-31 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 11 0 0.00 0 0.0000
2020-11-12 2020-09-30 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 11 -1,000 -98.91 0 -100.00
2020-07-31 2020-06-30 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 1,011 1,000 9,090.91 1 0.0000
2020-05-01 2020-03-31 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 11 0 0.00 0 -100.00 0.0000
2020-02-14 2019-12-31 13F TONIX PHARMACEUTICALS HLDG C COM 890260706 11 -103 -90.35 0 0.0000
2019-11-14 2019-09-30 13F TONIX PHARMACEUTICALS HLDG C COM NEW 890260508 114 -8,288 -98.64 0 -100.00
2019-08-14 2019-06-30 13F TONIX PHARMACEUTICALS HLDG C COM NEW 890260508 8,402 1,814 27.53 12 -25.00 0.0000
2019-05-14 2019-03-31 13F TONIX PHARMACEUTICALS HLDG C COM NEW 890260508 6,588 6,478 5,889.09 16 33.33 0.0000
2019-02-14 2018-12-31 13F TONIX PHARMACEUTICALS HLDG C COM NEW 890260508 110 -2,440 -95.69 0 -100.00
2018-11-14 2018-09-30 13F TONIX PHARMACEUTICALS HLDG C COM 890260409 2,550 2,450 2,450.00 2 0.0000
2018-08-14 2018-06-30 13F TONIX PHARMACEUTICALS HLDG C COM 890260409 100 -4,299 -97.73 0 -100.00
2018-05-15 2018-03-31 13F TONIX PHARMACEUTICALS HLDG C COM 890260409 4,399 3,899 779.80 14 600.00 0.0000
2018-02-14 2017-12-31 13F TONIX PHARMACEUTICALS HLDG C COM 890260409 500 -1,803 -78.29 2 -80.00 0.0000
2017-11-14 2017-09-30 13F TONIX PHARMACEUTICALS HLDG C COM 890260409 2,303 1,803 360.60 10 400.00 0.0000
2017-11-14 2017-06-30 13F/A-1 TONIX PHARMACEUTICALS HLDG C COM 890260409 500 -373 -42.73 2 -50.00 0.0000
2017-08-14 2017-06-30 13F TONIX PHARMACEUTICALS HLDG C COM 890260409 500 -373 2
2017-11-14 2017-03-31 13F/A-1 TONIX PHARMACEUTICALS HLDG C COM 890260409 873 873 4 0.0000
2017-05-12 2017-03-31 13F TONIX PHARMACEUTICALS HLDG C COM 890260409 873 -4,127 4
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.